Mackay Shields LLC Nevro Corp Transaction History

Mackay Shields LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $665,520 - $841,582	-4,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $212,496 - $291,488	-1,600 Reduced 25.4%	4,700 $655,000
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $221,071 - $294,944	-1,600 Reduced 20.25%	6,300 $1.09 Million
Q3 2020 Nov 04, 2020	BUY	$114.09 - $145.51 $467,769 - $596,591	4,100 Added 107.89%	7,900 $1.1 Million
Q2 2020 Jul 31, 2020	SELL	$89.45 - $129.85 $983,950 - $1.43 Million	-11,000 Reduced 74.32%	3,800 $454,000
Q1 2020 May 08, 2020	BUY	$70.23 - $144.31 $1.04 Million - $2.14 Million	14,800 New	14,800 $1.48 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $143M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.